MarketCap
Facebook
X
TelegramFluidigm Corporation Betriebsaufwand | FLDM
Betriebsaufwand Jährlich Fluidigm Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 134 M | 116 M | 110 M | 110 M | 132 M | 122 M | 115 M | 68.4 M | 55.1 M | 45.2 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 134 M | 45.2 M | 101 M |
Betriebsaufwand anderer Aktien in der Diagnostik & Forschung
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K |  USA |
 |
QIAGEN N.V.
QGEN
|
821 M | - | - | $ 10.6 B |  Niderland |
 |
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Charles River Laboratories International
CRL
|
607 M | $ 280.05 | 0.13 % | $ 13.9 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 234.4 | 0.08 % | $ 26 B | USA |
 |
Biomerica
BMRA
|
5.64 M | $ 1.58 | 3.18 % | $ 3.63 M | USA |
 |
DarioHealth Corp.
DRIO
|
49.3 M | $ 7.59 | 3.48 % | $ 30.2 M |  Israel |
 |
Aspira Women's Health
AWH
|
13.8 M | - | -6.19 % | $ 10.5 M | USA |
 |
Celcuity
CELC
|
172 M | $ 92.0 | 6.24 % | $ 4.3 B | USA |
 |
Co-Diagnostics
CODX
|
50.6 M | $ 1.4 | 0.68 % | $ 1.86 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M |  Britain |
 |
Check-Cap Ltd.
CHEK
|
14.1 M | - | - | $ 9.42 M | Israel |
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
DexCom
DXCM
|
1.89 B | $ 89.75 | 0.75 % | $ 35 B | USA |
 |
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Interpace Biosciences
IDXG
|
20 M | $ 1.66 | 0.6 % | $ 7.34 M | USA |
 |
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | USA |
 |
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | China |
 |
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | USA |
 |
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | USA |
 |
Exact Sciences Corporation
EXAS
|
2.47 B | - | - | $ 19.8 B | USA |
 |
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
Soleno Therapeutics
SLNO
|
181 M | - | - | $ 2.69 B | USA |
 |
Psychemedics Corporation
PMD
|
8.99 M | - | -1.84 % | $ 15.3 M | USA |
 |
Motus GI Holdings
MOTS
|
19.1 M | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
408 M | $ 163.15 | 0.19 % | $ 12.8 B |  Irlanda |
 |
Syneos Health
SYNH
|
4.12 B | - | - | $ 4.46 B | USA |
 |
Invitae Corporation
NVTA
|
343 M | - | - | $ 21.2 M | USA |
 |
Organovo Holdings
ONVO
|
23.3 M | - | -2.3 % | $ 19.4 M | USA |
 |
IQVIA Holdings
IQV
|
2.94 B | $ 236.66 | 0.28 % | $ 40.7 B | USA |
 |
OpGen
OPGN
|
21.9 M | - | -16.95 % | $ 1.54 M | USA |
 |
T2 Biosystems
TTOO
|
38.2 M | - | -39.35 % | $ 313 K | USA |
 |
Anixa Biosciences
ANIX
|
9.98 M | $ 3.18 | 0.93 % | $ 103 K | USA |
 |
PerkinElmer
PKI
|
1.07 B | - | -0.91 % | $ 14.7 B | USA |
 |
Meridian Bioscience
VIVO
|
134 M | - | - | $ 1.49 B | USA |
 |
ENDRA Life Sciences
NDRA
|
5.76 M | $ 4.47 | 1.36 % | $ 3.52 M | USA |
 |
Quotient Limited
QTNT
|
119 M | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Renalytix AI plc
RNLX
|
29.8 M | - | 5.66 % | $ 22.7 M | Britain |
 |
Natera
NTRA
|
258 M | $ 309.93 | 1.04 % | $ 42.4 B | USA |
 |
Myriad Genetics
MYGN
|
964 M | $ 3.03 | 0.62 % | $ 281 M | USA |
 |
NeoGenomics
NEO
|
430 M | $ 15.94 | 0.24 % | $ 2.04 B | USA |
 |
National Research Corporation
NRC
|
38.5 M | $ 21.19 | 0.84 % | $ 474 M | USA |
 |
Surmodics
SRDX
|
26.4 M | - | - | $ 608 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
7.12 B | $ 27.29 | 0.51 % | $ 25.9 B | Niderland |
 |
Quidel Corporation
QDEL
|
285 M | $ 14.3 | 1.75 % | $ 602 M | USA |